Study Objectives: Sepsis is a major cause of morbidity and mortality worldwide. With the advance of medical care, the mortality of sepsis has decreased in the past decades. Many treatments and diagnostic tools recommended by the consensus meetings, however, still lack supporting evidence.
Methods: We conducted a retrospective population-based cohort study with propensity score matched sub-cohorts based on a prospectively collected national longitudinal health insurance database in Taiwan. Severe sepsis-associated hospital admissions from 2000 to 2011 based on ICDs-9th CM codes of infections and acute organ dysfunction were identified. To compare the effectiveness of treatment and diagnostic tool, propensity scores were generated to match the comparable control groups.
Results: During the 12-year period, 33,375 patients and 50,465 hospitalizations of severe sepsis were identified. The age-standardized 28-day in-hospital mortality decreased significantly since the year 2008 (from 21% in 2008 to 15% in 2011) with increasingly implemented treatment and diagnostic tool. After propensity score matching, measurement of procalcitonin and lactate were found to be significantly associated with lower mortality rate (OR:0.70 and 0.90, 95% C.I.:0.61-0.81 and 0.84-0.97, respectively), as well as some of the treatment modules (packed red blood cell, OR:0.60, 95% C.I.:0.52-0.69; albumin, OR:0.72, 95% C.I.: 0.55-0.93; balanced crystalloid, OR: 0.29, 95% C.I.:0.20-0.41) and dopamine (compared to norepinephrine, OR: 0.44, 95% C.I.: 0.39-0.49) Conclusions: The decreasing mortality was found to be associated with some of the increasingly utilized treatment and diagnostic tool. However, inconsistent findings between our observations and many experimental trials need to be further validated. Study Objectives: Trichomonas vaginalis is the most common non-viral sexually transmitted infections in women. However, T. vaginalis has not been studied in male emergency department (ED) patients. Challenges with the diagnosis of T. vaginalis in male ED patients include that up to 75% of infected men can be asymptomatic, and there are no U.S. Food and Drug Administration (FDA)-approved rapid diagnostic tests in men. The OSOM Trichomonas Test is a FDA-approved point-of-care immunochromatographic capillary flow dipstick for the diagnosis of T. vaginalis in women using a vaginal swab. The objective of our study was compare the sensitivity of the OSOM Trichomonas Test compared to the gold-standard APTIMA T. vaginalis assay, a nucleic acid amplification test (NAAT). The OSOM Trichomonas Test has not previously been evaluated in men.
Methods: We prospectively enrolled 158 male ED patients between the ages of 18-40 years who reported having at least 1 penile-vaginal act of sexual intercourse in the last month without using a condom. We had complete data on 147 subjects. Study subjects provided a urine sample from which we performed the OSOM Trichomonas Test and the APTIMA T. vaginalis assay. All subjects' positive for T. vaginalis by the APTIMA test were treated with metronidazole.
Results: We found that 27/151 (17.9%) of urine samples were positive by the OSOM Trichomonas Test and 8/148 (5.3%) of urine samples were positive by the APTIMA T. vaginalis assay. Three subjects with a positive OSOM Trichomonas Test were also positive by the APTIMA T. vaginalis assay. When compared to the APTIMA T. vaginalis assay, the OSOM Trichomonas Test had a sensitivity of 37.5% (95% CI 8.5-75.5%), specificity of 82.9% (95% CI 75.6-88.7%), positive predictive value of 11.1% (4.5-24.7%), and negative predictive value of 95.9% (93.1-97.6%) for T. vaginalis. Using a 2x2 contingency table and Fisher's exact test, the difference between the 2 T. vaginalis tests was significant (p ¼ 0.001).
Conclusions: While the OSOM Trichomonas Test has high sensitivity for diagnosing T. vaginalis from vaginal swabs in women, it lacks adequate sensitivity to be clinically useful in diagnosing T. vaginalis in the urine of men. Study Objectives: Dog-assisted therapy (DAT) has been shown to be useful in improving educational, psychological, and motivational effectiveness in regards to patient recovery. Petting dogs has been shown to have relaxing effects mediated by the release of serotonin, prolactin, and oxytocin, and has significant positive effects on cardiovascular health. Dogs are known to be a major reservoir for both viral and bacterial zoonotic infections including Rabies, Norovirus, Pasturella, Salmonella, Campylobacter, Bordatella, Coxiella, and methicillin-resistant Staphylococcus aureus (MRSA). There have been some case reports illustrating the possibility of transmission of antibiotic-resistant bacteria causing infection from pets to humans. This study sought to determine the presence of common "problematic" pathogens potentially carried by a group of emergency department (ED) therapy dogs, namely MRSA, E. Coli, Clostridium difficile, and Pseudomonas. It is hypothesized that the incidence of positive cultures would be negligible.
Methods: A convenience sample of 7 therapy dogs was swabbed (coat, nose, and paws) before and after walking through the ED visiting patients. One perianal swab from each dog was obtained to test for Clostridium difficile (C. diff ). Samples were cultured on plates containing Blood Agar, Chocolate Agar, Colistin and Naladixic acid (CNA), and MacConkey Agar (MAC). These culture mediums were specifically selected to optimize the growth of the pathogens of concern. A rapid membrane enzyme immunoassay for the simultaneous detection of C. diff glutamate dehydrogenase antigen and toxins A and B in a single reaction well was used to assess for C. diff. This test serves as a screen for the presence of C. diff and confirms the presence of toxigenic C. diff by detecting toxins A and B in fecal specimens. The rate (presence/absence) of pathogens was quantified for each dog during each session (pre/ post). Paired samples t-tests were utilized to test for statistical significance (p < 0.05).
Results: The study involved 7 dogs of different breeds, including Golden Retrievers, Miniature Poodle, and Great Dane. The dogs were led through the department by their handler, and per protocol, did not visit the critically ill and suicidal patients. Upon arrival, all tests at baseline were negative for all 7 dogs. Following the dogs' visits through the emergency department, all tests were negative for the 7 dogs on post-measure. Microbial analysis of the collected samples revealed that all 7 dogs carried commensal skin flora, even after very close contact with the patients who involved petting, hugging, and kissing the dogs. There was no growth of the pathogens of concern, namely E. coli, MRSA, C. diff, and Pseudomonas.
Conclusions: Although there have been rare case reports of clinically significant transmission of microbial agents from domestic pets to humans, this study helps to demonstrate that pet therapy dogs do not pose a potential clinical harm to patients in the emergency department setting. Study Objectives: Value-based purchasing (VBP) is a quality incentive program under the Affordable Care Act that is funded by a 2% reduction from diagnosis-related group (DRG) payments for the 2018 fiscal year. One-quarter of this fund is determined by patient and caregiver-centered experience and care coordination. Therefore, patient satisfaction scores have become an increasingly important component of health care delivery. Few studies have sought to identify low-cost interventions that improve patient experience and subsequently patient satisfaction scores. Here, we aim to explore the impact of popsicle administration in pediatric emergency department (ED) patients on Press Ganey satisfaction scores.
Methods: A prospective trial was conducted at a tertiary academic pediatric ED and one mid-sized community ED between January 2018 to March 2018. The intervention was to give a popsicle to all eligible patients 0-14 years of age on even-numbered days (popsicle days) versus conventional practice on odd-numbered days. Press Ganey top box scores (response to the question was a "5" or the highest value) between even-and oddnumbered days were then compared using 2-sample t and chi-square tests.
Results: Among the 152 pediatric patients included (0-14 years of age), 84 surveys were filled out on even days and 68 surveys were filled out on odd days. Baseline demographics were similar between the groups with an average age of 7.3 AE 6.0 years and no statistical difference between the number of male and female patients. Overall, there was a significant increase in patient satisfaction scores on popsicle administration days for questions that asked about physician's concern for comfort 74% versus 58% (p < 0.05), physician's courtesy 77% versus 62% (p < 0.04), and physician taking time to listen 74% versus 57% (p < 0.03). No statistical difference was observed for questions that asked about overall rating of care 64% versus 61% (p¼ 0.64), likelihood of recommending 66 versus 59% (p¼0.37), or informed of treatment 74% versus 60% (p¼0.07).
Conclusions: Offering popsicles to all eligible pediatric emergency department patients resulted in an increase in Press Ganey patient satisfaction score regarding physician's concern for comfort, courtesy, and listening. Further studies should increase sample size, assess subsets of age groups, and assess economic rate of return for this and other low-cost interventions that might significantly impact perceived health care quality.
Feasibility of Delivering Patiromer Through Enteral Feeding Tubes
Gross C, Bartis J, Nwachukwu F, Ono R, Li L/Relypsa, Inc, a Vifor Pharma Group Company, Redwood City, CA Study Objectives: Patiromer is a sodium-free potassium binder approved for the treatment of hyperkalemia (HK) in the U.S. and E.U. The efficacy and safety of patiromer in pediatric patients are currently under investigation (EMERALD, NCT03087058). Patiromer in doses of 8.4, 16.8, and 25.2 g is supplied as a powder, and based on the label should be reconstituted in 1/3 c. water (w80 mL) to obtain a suspension for oral administration. This presents a clinical challenge because pediatric patients with chronic kidney disease and HK may use enteral feeding tubes for nutritional needs and medication administration. The objective of this series of experiments was to evaluate the feasibility of patiromer delivery through enteral feeding tubes.
Methods: Patiromer suspensions delivered via syringe (12, 35, and 60 mL) through nasogastric (NG; 5, 6.5, 8, and 14 Fr) and gastrostomy tubes (GT; 12 and 14 Fr) were evaluated under gravity flow. Dose recovery and flow rate were determined based on tube diameter and suspension concentration (4.2, 8.4, 16.8, and 25 .2 g in 80 and/or 90 mL water). Clumping and adherence of drug product to the tubing wall were also evaluated. Force applied to the syringe to facilitate delivery of patiromer to the tubes was assessed using the 8.4 g dose suspended in 90 mL water.
Results: Patiromer 8.4 g/90 mL water was aspirated and delivered by syringe with no evidence of clogging or blockage. Dose recovery of patiromer suspensions of 4.2 to 16.8 g in 80 and/or 90 mL water through 5, 6.5 and 8 Fr NG and 12 Fr GT was 93-101%. Flow rate increased with decreasing suspension concentration (Figure) . Flow rate also increased with increasing tube diameter. Patiromer 4.2 to 16.8 g/80 mL suspensions flowed through all tubes tested except the 5 Fr NG tube, while patiromer 25.2 g/80 mL did not flow through any of the tubes tested. Significant adherence to the tube walls did not occur in tubes tested with 8.4 g suspensions. Application of gentle pressure to the syringe facilitated flow especially through smaller tubes.
Conclusions: Results showed that the delivery of patiromer at concentrations up to 8.4 g/80 mL through NG and GT of 6.5 Fr to 14 Fr is feasible, with delivery improving upon use of larger diameter tubes. Patiromer 16.8 g/80 mL is deliverable through tubes >8 Fr. It is possible that additional dilution or applied pressure will achieve flow through smaller feeding tubes or with patiromer doses >16.8 g; however, consideration should be made for hyperkalemic patients under fluid restriction. 
